148 related articles for article (PubMed ID: 25982916)
1. Changes in the pharmacokinetics of teicoplanin in patients with hyperglycaemic hypoalbuminaemia: Impact of albumin glycosylation on the binding of teicoplanin to albumin.
Enokiya T; Muraki Y; Iwamoto T; Okuda M
Int J Antimicrob Agents; 2015 Aug; 46(2):164-8. PubMed ID: 25982916
[TBL] [Abstract][Full Text] [Related]
2. Albumin concentration significantly impacts on free teicoplanin plasma concentrations in non-critically ill patients with chronic bone sepsis.
Brink AJ; Richards GA; Lautenbach EE; Rapeport N; Schillack V; van Niekerk L; Lipman J; Roberts JA
Int J Antimicrob Agents; 2015 Jun; 45(6):647-51. PubMed ID: 25819167
[TBL] [Abstract][Full Text] [Related]
3. [Specific variability of teicoplanin protein binding in patients receiving continuous hemodiafiltration-comparison with hypoalbuminemia patients].
Yanagimoto H; Teramatsu T; Goto J; Yanagisawa M; Harii N; Suzuki M; Hanawa T; Matsuda K; Oguchi T
Yakugaku Zasshi; 2013; 133(6):711-7. PubMed ID: 23558910
[TBL] [Abstract][Full Text] [Related]
4. [Effects of Teicoplanin on the PT-INR Controlled by Warfarin in Infection Patients].
Nakano T; Nakamura T; Nakamura Y; Irie K; Sato K; Matsuo K; Imakyure O; Ogata K; Mishima K; Kamimura H
Yakugaku Zasshi; 2017; 137(7):909-916. PubMed ID: 28674307
[TBL] [Abstract][Full Text] [Related]
5. Development of a teicoplanin loading regimen that rapidly achieves target serum concentrations in critically ill patients with severe infections.
Nakamura A; Takasu O; Sakai Y; Sakamoto T; Yamashita N; Mori S; Morita T; Nabeta M; Hirayu N; Yoshiyama N; Moroki M; Tashiro K; Kannae M
J Infect Chemother; 2015 Jun; 21(6):449-55. PubMed ID: 25726436
[TBL] [Abstract][Full Text] [Related]
6. Change of teicoplanin loading dose requirement for incremental increases of systemic inflammatory response syndrome score in the setting of sepsis.
Nakano T; Nakamura Y; Takata T; Irie K; Sano K; Imakyure O; Mishima K; Futagami K
Int J Clin Pharm; 2016 Aug; 38(4):908-14. PubMed ID: 27125378
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of teicoplanin concentrations and safety analysis in neonates.
Yamada T; Kubota T; Nakamura M; Ochiai M; Yonezawa M; Yano T; Kawashiri T; Egashira N; Hara T; Masuda S
Int J Antimicrob Agents; 2014 Nov; 44(5):458-62. PubMed ID: 25218156
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of total and unbound teicoplanin concentrations and dosing simulations in patients with haematological malignancy.
Byrne CJ; Parton T; McWhinney B; Fennell JP; O'Byrne P; Deasy E; Egan S; Enright H; Desmond R; Ryder SA; D'Arcy DM; McHugh J; Roberts JA
J Antimicrob Chemother; 2018 Apr; 73(4):995-1003. PubMed ID: 29272419
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of sequential intravenous and subcutaneous teicoplanin in critically ill patients without vasopressors.
Barbot A; Venisse N; Rayeh F; Bouquet S; Debaene B; Mimoz O
Intensive Care Med; 2003 Sep; 29(9):1528-34. PubMed ID: 12856119
[TBL] [Abstract][Full Text] [Related]
10. Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: lessons from the DALI Study.
Roberts JA; Stove V; De Waele JJ; Sipinkoski B; McWhinney B; Ungerer JP; Akova M; Bassetti M; Dimopoulos G; Kaukonen KM; Koulenti D; Martin C; Montravers P; Rello J; Rhodes A; Starr T; Wallis SC; Lipman J;
Int J Antimicrob Agents; 2014 May; 43(5):423-30. PubMed ID: 24630304
[TBL] [Abstract][Full Text] [Related]
11. In vitro protein binding of teicoplanin to neonatal serum.
Sando M; Sato Y; Iwata S; Akita H; Sunakawa K
J Infect Chemother; 2004 Oct; 10(5):280-3. PubMed ID: 16163462
[TBL] [Abstract][Full Text] [Related]
12. A simplified chart for determining the initial loading dose of teicoplanin in critically ill patients.
Yoshida S; Suzuki A; Ohmori T; Niwa T; Okada H; Suzuki K; Kobayashi R; Doi T; Kitaichi K; Matsuura K; Murakami N; Ogura S; Itoh Y
Pharmazie; 2017 Jan; 72(1):53-57. PubMed ID: 29441898
[TBL] [Abstract][Full Text] [Related]
13. Comparison of breakthrough Gram-positive cocci infection during vancomycin vs teicoplanin therapy in patients receiving haematopoietic stem cell transplantation.
Ohata K; Kitagawa J; Niwa T; Takahashi-Yamauchi T; Harada S; Matsumoto T; Nakamura N; Nakamura H; Kanemura N; Shimizu M; Suzuki A
J Clin Pharm Ther; 2020 Dec; 45(6):1342-1348. PubMed ID: 32656902
[TBL] [Abstract][Full Text] [Related]
14. The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients.
Ulldemolins M; Roberts JA; Rello J; Paterson DL; Lipman J
Clin Pharmacokinet; 2011 Feb; 50(2):99-110. PubMed ID: 21142293
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of teicoplanin dosing designs to achieve a new target trough concentration.
Ueda T; Takesue Y; Nakajima K; Ichki K; Wada Y; Tsuchida T; Takahashi Y; Ishihara M; Tatsumi S; Kimura T; Ikeuchi H; Uchino M
J Infect Chemother; 2012 Jun; 18(3):296-302. PubMed ID: 22065089
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of Therapeutic Drug Monitoring of Teicoplanin at the Onset of Febrile Neutropenia.
Takigawa M; Tanaka H; Suwa J; Obara T; Maeda Y; Sato M; Shimazaki Y; Onoda T; Ishigami A; Ishii T
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109716
[No Abstract] [Full Text] [Related]
17. Improvement of Predictivity of Teicoplanin Serum Trough Concentrations at Steady State Calculated by Vancomycin Pharmacokinetic Parameter.
Kobayashi R; Otomo S; Shiba Y; Ebinuma K; Sudoh T
Yakugaku Zasshi; 2016; 136(11):1557-1562. PubMed ID: 27803487
[TBL] [Abstract][Full Text] [Related]
18. Significance of individual adjustment of initial loading dosage of teicoplanin based on population pharmacokinetics.
Niwa T; Imanishi Y; Ohmori T; Matsuura K; Murakami N; Itoh Y
Int J Antimicrob Agents; 2010 May; 35(5):507-10. PubMed ID: 20185275
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical localization and pharmacokinetics of the anti-MRSA drug teicoplanin in rat kidney using a newly developed specific antibody.
Yamamoto Y; Yamamoto Y; Saita T; Shin M
Med Mol Morphol; 2021 Sep; 54(3):227-236. PubMed ID: 33864519
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of teicoplanin administered by subcutaneous or intravenous route and simulation of optimal loading dose regimen.
Cazaubon Y; Venisse N; Mimoz O; Maire P; Ducher M; Bourguignon L; Goutelle S
J Antimicrob Chemother; 2017 Oct; 72(10):2804-2812. PubMed ID: 29091222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
